Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Chiorazzi

Showing results (131-140 of 167) with videos related to

Pageof 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2023
Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft ModelShih-Shih Chen, Jacqueline C Barrientos, Gerardo Ferrer, et al.
Blood|March 16, 2018
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLLMichael Hallek, Bruce D Cheson, Daniel Catovsky, et al.
Blood|April 24, 2019
IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemiaAnnika Scheffold, Billy Michael Chelliah Jebaraj, Eugen Tausch, et al.
Frontiers in Oncology|June 11, 2021
Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical CourseDavide Bagnara, Catherine Tang, Jennifer R Brown, et al.
Experimental Hematology|January 9, 2021
Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemiaGonzalo Blanco, Anna Puiggros, Barbara Sherry, et al.
Blood|October 17, 2012
IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functionsPiers E M Patten, Charles C Chu, Emilia Albesiano, et al.
Blood|March 10, 2011
A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the diseaseDavide Bagnara, Matthew S Kaufman, Carlo Calissano, et al.
Leukemia & Lymphoma|April 5, 2017
FcγRIIb expression in early stage chronic lymphocytic leukemiaRosa Bosch, Alba Mora, Eva Puy Vicente, et al.
Blood|December 1, 2005
Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational statusMia Thorsélius, Alexander Kröber, Fiona Murray, et al.
JCI Insight|February 1, 2017
Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinibJan A Burger, Kelvin W Li, Michael J Keating, et al.
Pageof 17

Showing results (131-140 of 167) with videos related to

Sort By:
Pageof 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2023
Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft ModelShih-Shih Chen, Jacqueline C Barrientos, Gerardo Ferrer, et al.
Blood|March 16, 2018
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLLMichael Hallek, Bruce D Cheson, Daniel Catovsky, et al.
Blood|April 24, 2019
IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemiaAnnika Scheffold, Billy Michael Chelliah Jebaraj, Eugen Tausch, et al.
Frontiers in Oncology|June 11, 2021
Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical CourseDavide Bagnara, Catherine Tang, Jennifer R Brown, et al.
Experimental Hematology|January 9, 2021
Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemiaGonzalo Blanco, Anna Puiggros, Barbara Sherry, et al.
Blood|October 17, 2012
IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functionsPiers E M Patten, Charles C Chu, Emilia Albesiano, et al.
Blood|March 10, 2011
A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the diseaseDavide Bagnara, Matthew S Kaufman, Carlo Calissano, et al.
Leukemia & Lymphoma|April 5, 2017
FcγRIIb expression in early stage chronic lymphocytic leukemiaRosa Bosch, Alba Mora, Eva Puy Vicente, et al.
Blood|December 1, 2005
Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational statusMia Thorsélius, Alexander Kröber, Fiona Murray, et al.
JCI Insight|February 1, 2017
Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinibJan A Burger, Kelvin W Li, Michael J Keating, et al.
Pageof 17